Study Title

Takeda 205

Purpose

To assess the safety and effectiveness of treatment with daily oral administration of dexlansoprazole 30 or 60 mg for 8 to 12 weeks in pediatric subjects aged 1 to 11 years, inclusive, with Erosive Esophagitis.

Eligibility

Study Process